Related Experiment Video

Updated: Apr 28, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

7.7K

Managing the patent ductus arteriosus: current treatment options

Anne Marie Heuchan1, Ronald I Clyman2

  • 1Department of Neonatology, Royal Hospital for Sick Children, Glasgow, UK.

Archives of Disease in Childhood. Fetal and Neonatal Edition
|June 7, 2014
PubMed

Insights

Optimal management of patent ductus arteriosus (PDA) in premature infants is debated. Current research lacks long-term data on PDA treatment effects, necessitating further investigation into evolving therapies for very premature infants.

Area of Science:

  • Neonatalogy
  • Pediatric Cardiology
  • Perinatology

Background:

  • The management of patent ductus arteriosus (PDA) in premature infants is a persistent clinical challenge.
  • While a persistent PDA is often considered detrimental, definitive evidence regarding the long-term benefits or harms of its treatment is limited.
  • Existing clinical trials primarily focus on short-term treatment effects, not prolonged PDA exposure.

Purpose of the Study:

  • To review the current literature on patent ductus arteriosus (PDA) management in premature infants (<28 weeks' gestational age).
  • To evaluate existing treatment options, including non-interventional approaches.
  • To discuss future research directions for optimizing PDA treatment in this vulnerable population.

Main Methods:

  • Comprehensive review of existing scientific literature on PDA in premature neonates.
  • Analysis of data from clinical trials and observational studies.
  • Synthesis of information on current and emerging therapeutic strategies.

Main Results:

  • Robust evidence on the long-term impact of PDA treatment on morbidity and mortality in very premature infants is lacking.
  • The effectiveness of current treatments for prolonged PDA exposure has not been adequately studied in the context of modern neonatal care (antenatal corticosteroids, surfactant, non-invasive support).
  • Novel therapies and individualized risk assessment approaches are emerging.

Conclusions:

  • Further research is essential to establish optimal management strategies for PDA in premature infants.
  • New insights and therapies promise improved individual patient assessment and treatment optimization.
  • The evolving landscape of neonatal care necessitates re-evaluation of PDA management guidelines.

Keywords:
CardiologyNeonatology

More Related Videos

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

2.0K
Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
532
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
591
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
673
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
412
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
445